Gainers
- Revance Therapeutics (NASDAQ:RVNC) shares increased by 15.3% to $24.0 during Thursday's pre-market session. The company's market cap stands at $1.7 billion.
- Ayala Pharmaceuticals (NASDAQ:AYLA) stock rose 14.28% to $2.0. The market value of their outstanding shares is at $29.5 million.
- Idera Pharmaceuticals (NASDAQ:IDRA) shares moved upwards by 13.59% to $0.57. The company's market cap stands at $30.1 million.
- AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 13.21% to $0.33. The company's market cap stands at $48.2 million.
- PhaseBio Pharmaceuticals (NASDAQ:PHAS) shares increased by 13.2% to $1.2. The company's market cap stands at $59.8 million.
- ORIC Pharmaceuticals (NASDAQ:ORIC) shares moved upwards by 13.04% to $3.9. The market value of their outstanding shares is at $154.3 million.
Losers
- Chembio Diagnostics (NASDAQ:CEMI) stock fell 15.4% to $0.53 during Thursday's pre-market session. The company's market cap stands at $16.0 million.
- Biophytis (NASDAQ:BPTS) stock declined by 11.72% to $0.98. The market value of their outstanding shares is at $16.0 million.
- Nanobiotix (NASDAQ:NBTX) stock fell 10.49% to $3.84. The company's market cap stands at $133.9 million.
- BioVie (NASDAQ:BIVI) stock declined by 8.04% to $2.86. The company's market cap stands at $81.8 million.
- Apexigen (NASDAQ:APGN) shares declined by 7.15% to $7.02. The market value of their outstanding shares is at $150.5 million.
- Spero Therapeutics (NASDAQ:SPRO) stock declined by 7.0% to $1.33. The market value of their outstanding shares is at $46.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
